Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C&F Financial Corp CFFI Feb 23, 2017 48.10 +0.21   
 C.H. Robinson Worldwide CHRW Feb 23, 2017 79.46 +0.06   
 CA Inc CA Feb 23, 2017 32.25 +0.09   
 Cabot Microelectronics Corp CCMP Feb 23, 2017 69.61 -0.06   
 Cache Inc CACH Feb 23, 2017 0.00 0.00   
 Cadence Design Systems CDNS Feb 23, 2017 30.78 -0.26   
 Cadence Pharmaceuticals CADX Feb 23, 2017 13.98 0.00   
 Cadiz Inc CDZI Feb 23, 2017 14.75 -1.01   
 Caesars Acquisition Company CACQ Feb 23, 2017 14.25 +1.42   
 Caesars Entertainment Corporati CZR Feb 23, 2017 9.30 +2.76   
 Caesarstone Sdot-Yam Ltd CSTE Feb 23, 2017 33.90 -1.17   
 Cafepress Inc PRSS Feb 23, 2017 3.17 -1.86   
 Cal-Maine Foods CALM Feb 23, 2017 38.10 -0.78   
 Caladrius Biosciences, Inc. CLBS Feb 23, 2017 5.25 +2.94   
 Calamos Asset Management CLMS Feb 23, 2017 8.28 0.00   
 Calamos Convertible and High CHY Feb 23, 2017 11.36 +0.26   
 Calamos Convertible Opportunities CHI Feb 23, 2017 10.92 +0.09   
 Calamos Dynamic Convertible & Income Fund CCD Feb 23, 2017 18.92 -1.30   
 Calamos Global Dynamic CHW Feb 23, 2017 7.77 +0.52   
 Calamos Global Total Return Fund CGO Feb 23, 2017 11.58 +0.35   
 Calamos Strategic Total Return Fund CSQ Feb 23, 2017 11.13 +0.72   
 Calamp Corp CAMP Feb 23, 2017 15.65 -0.63   
 Calavo Growers CVGW Feb 23, 2017 58.15 0.00   
 California First National Bancorp CFNB Feb 23, 2017 15.80 -0.94   
 California United Bk CUNB Feb 23, 2017 39.60 -0.38   
 Callidus Software CALD Feb 23, 2017 19.75 -1.00   
 Calumet Specialty Products CLMT Feb 23, 2017 4.00 +5.26   
 Cambium Learning Group ABCD Feb 23, 2017 4.98 +1.84   
 Cambridge Capital Aquisition CAMBU Feb 23, 2017 10.60 0.00   
 Camco Financial Corp CAFI Feb 23, 2017 0.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK